Related Federal Cases
- DoorDash Inc, Skimming Dasher Tips, New York, 2023 · New York
- Mylan Inc, Deceptively Fueling Opioid Crisis, New York NY, 2023 · Washington
- Viviane Cazeau, Bank Fraud Scheme, Massachusetts, 2023 · Florida
- Jon D. Zapisek, Willful Failure to File Tax Returns, Richfields MA,… · Utah
- Cedric Cromwell, Major Drug Trafficking, Massachusetts, 2020 · Massachusetts
Perrotta Pharmacy Inc. – Failure to Keep Proper Records, Massachusetts 2023
BOSTON – In a shocking revelation, Perrotta Pharmacy Inc., DBA Perrotta’s Super Drug, in Lawrence, Massachusetts, has been accused of failing to keep proper records of controlled substances and maintaining effective controls against drug diversion. The U.S. Attorney’s Office announced today that the pharmacy has agreed to pay $30,000 and enter into a Corrective Action Plan with the government to resolve the allegations.
According to the settlement, pharmacists and staff at Perrotta’s Super Drug on multiple occasions failed to comply with recordkeeping requirements of the Controlled Substances Act. The violations included failure to maintain complete and accurate inventories of controlled substances, including medications such as oxycodone; failure to record all of the required information pertaining to listed chemical retail sales; and failure to maintain records documenting the training of sales personnel of listed chemical products.
The pharmacy’s failure to maintain proper records has raised concerns about the potential for drug diversion and the misuse of controlled substances. The U.S. Attorney’s Office has taken a strong stance against pharmacies that fail to comply with recordkeeping requirements, and this settlement is a clear indication of the consequences of such actions.
Perrotta’s Super Drug, an independently owned pharmacy, cooperated with the federal investigation and has agreed to implement a corrective action plan to come into compliance with the recordkeeping requirements of the Controlled Substance Act. The pharmacy has also agreed to permit federal law enforcement to perform inspections of the pharmacy during the next three years without a warrant.
United States Attorney Andrew E. Lelling and Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration, New England Division, made the announcement today. The case was handled by Assistant U.S. Attorney Jessica Weber of Lelling’s Civil Division.
The settlement serves as a reminder to pharmacies of the importance of maintaining accurate and complete records of controlled substances. The U.S. Attorney’s Office will continue to work tirelessly to ensure that pharmacies are held accountable for their actions and that the public is protected from the potential risks associated with drug diversion.
Perrotta Pharmacy Inc. has agreed to pay $30,000 to settle the allegations, a paltry sum compared to the potential consequences of their actions. The Corrective Action Plan will also require the pharmacy to implement new procedures and protocols to ensure compliance with the Controlled Substances Act.
Key Facts
- State: Massachusetts
- Category: Drug Trafficking|Fraud & Financial Crimes|Violent Crime
- Source: DOJ Press Release â†â€â€
ðŸâ€Â’ Get the grimiest stories delivered weekly. Subscribe free →
MORE FEDERAL CRIME NEWS
US NewsUS NewsUS NewsUS News